Canaccord lowers AeroVironment stock price target on timing concerns

Canaccord cut its AeroVironment (AVAV) price target to $280 from $300 while keeping a Buy rating, citing conservative timing for fiscal 2027 defense bill passage. The firm expects contract awards tied to a $350B supplemental reconciliation bill (including $54.6B DAWG funding) only in 2H fiscal 2027, pushing uncertainty despite upside to the initial 10% revenue growth guidance. Recent results still showed strong momentum—FY2026 Q4 revenue about $642M (+31% organic) with non-GAAP EPS $1.84 vs $1.48 forecast—but another analyst (Stifel) lowered its target from $315 to $220 due to rising capex.

Analysis

The market is still pricing AVAV as if budget timing is a clean catalyst, but the real variable is whether procurement gets pulled into this fiscal year or pushed into the next. That distinction matters more than the headline revenue growth rate because this name already trades on a premium multiple; a timing slip can compress the stock faster than the underlying program value can build. In other words, the setup is less “missed demand” and more “delayed monetization,” which is exactly where high-multiple defense names tend to de-rate.

Second-order, the competitive takeaway is that AVAV’s test performance strengthens its negotiating position for counter-UAS and directed-energy content, but it does not instantly translate into budget capture. Bigger primes like LMT can still win the larger platform-level envelope once requirements are standardized, even if they are not the best-in-class demo winner today. That creates a split: AVAV may own the technology narrative, while LMT owns the back-end scaling and integration economics if the program matures.

The contrarian point is that consensus is treating the bill as a binary upside event, when the more important risk is duration. If awards land in the second half of the fiscal year, the equity may be forced to bridge several quarters with only narrative support, which is dangerous for a stock already near a low but still priced for strong execution. Any delay beyond that window should be viewed as a falsifier for near-term rerating, even if the long-term program thesis remains intact.

Key Decisions for Investors

• Do not chase AVAV on analyst target moves alone; wait for either confirmed reconciliation passage or a price retest closer to the $130s before considering entry. Risk/reward is poor above current levels if the bill timing slips.
• If the legislative calendar turns constructive, consider a tactical long AVAV / short LMT pair for 1-3 months. AVAV should have the higher beta to program awards, while LMT is less sensitive to this specific directed-energy optionality.
• If no award timing clarity emerges into the next budget window, fade AVAV strength via a short against a defense basket or LMT. The thesis breaks if management raises FY27 guidance or announces an earlier-than-expected contract award.
• Watch VPG as a second-order beneficiary only on real procurement conversion, not test headlines. It is a cleaner way to express broader defense electronics content growth, but it needs actual order flow to justify rerating.